Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Research article

Hemoptysis due to fungus ball after tuberculosis: A series of 21 cases treated with hemostatic radiotherapy

Authors: Lucas G Sapienza, Maria José L Gomes, Carmelindo Maliska, Antonio N Norberg

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

In patients who are not amenable to surgical resection (cavernostomy), it is difficult to achieve palliation of hemoptysis from pulmonary aspergilloma. There are only 9 cases with a short follow-up that have reported the use of radiotherapy for hemoptysis in this scenario.

Methods

A retrospective series of 21 patients with chronic necrotizing pulmonary aspergillosis were treated with radiotherapy (20 Gray) from 1990 to 2002. The outcome measures were the period from tuberculosis treatment to the onset of hemoptysis, hemoptysis resolution rate, change in Zubrod performance status after 30 days of the completion of radiotherapy, local failure-free survival, and overall survival.

Results

The median time between tuberculosis treatment and the onset of hemoptysis due to aspergilloma was 9 years. After radiotherapy, general status improved and the hemoptysis resolved in all patients. During the follow-up period, 4 failures occurred, with a 5-year local failure-free survival rate of 82 % and a 5-year overall survival rate of 59 %. Of these failures, 2 patients died due to recurrence of the hemoptysis, and 2 were rescued (using cavernostomy and reirradiation). The presence of chronic obstructive pulmonary disease (COPD) (p = 0.021) and female gender (p = 0.032) were negatively associated with overall survival. None of the variables was related to local control.

Conclusions

Based on these long-term data, radiotherapy is a potential option for controlling bleeding due to fungus balls. Female patients and COPD were associated with lower survival.
Literature
1.
go back to reference Binder RE, Faling LJ, Pugatch RD, Mahasaen C, Snider GL. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore). 1982;61:109–24.CrossRef Binder RE, Faling LJ, Pugatch RD, Mahasaen C, Snider GL. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore). 1982;61:109–24.CrossRef
2.
go back to reference Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis. 2003;37:265–80.CrossRef Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis. 2003;37:265–80.CrossRef
3.
go back to reference Izumikawa K, Tashiro T, Tashiro M, Takazono T, Kosai K, Morinaga Y, et al. Pathogenesis and clinical features of chronic pulmonary aspergillosis - is it possible to distinguish CNPA and CCPA clinically? J Infect Chemother. 2014;20:208–12.CrossRefPubMed Izumikawa K, Tashiro T, Tashiro M, Takazono T, Kosai K, Morinaga Y, et al. Pathogenesis and clinical features of chronic pulmonary aspergillosis - is it possible to distinguish CNPA and CCPA clinically? J Infect Chemother. 2014;20:208–12.CrossRefPubMed
4.
go back to reference Regnard J, Icard P, Nicolosi M, Spagiarri L, Magdeleinat P, Jauffret B, et al. Aspergilloma: a series of 89 surgical cases. Ann Thorac Surg. 2000;69:898–903.CrossRefPubMed Regnard J, Icard P, Nicolosi M, Spagiarri L, Magdeleinat P, Jauffret B, et al. Aspergilloma: a series of 89 surgical cases. Ann Thorac Surg. 2000;69:898–903.CrossRefPubMed
5.
go back to reference Nakamoto K, Takayanagi N, Kanauchi T, Ishiguro T, Yanagisawa T, Sugita Y. Prognostic factors in 194 patients with chronic necrotizing pulmonary aspergillosis. Intern Med. 2013;52:727–34.CrossRefPubMed Nakamoto K, Takayanagi N, Kanauchi T, Ishiguro T, Yanagisawa T, Sugita Y. Prognostic factors in 194 patients with chronic necrotizing pulmonary aspergillosis. Intern Med. 2013;52:727–34.CrossRefPubMed
6.
go back to reference Todeschini G, Murari C, Bonesi R, Pizzolo G, Verlato G, Tecchio C, et al. Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications. Eur J Clin Invest. 1999;29:453–7.CrossRefPubMed Todeschini G, Murari C, Bonesi R, Pizzolo G, Verlato G, Tecchio C, et al. Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications. Eur J Clin Invest. 1999;29:453–7.CrossRefPubMed
7.
go back to reference Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007;30:782–800.CrossRefPubMed Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007;30:782–800.CrossRefPubMed
8.
go back to reference Addrizzo-Harris DJ, Harkin TJ, Mcguinness G, Naidich DP, Rom WN. Pulmonary aspergilloma and AIDS* A comparison of HIV-infected and HIV-negative individuals. Chest. 1997;111:612–8.CrossRefPubMed Addrizzo-Harris DJ, Harkin TJ, Mcguinness G, Naidich DP, Rom WN. Pulmonary aspergilloma and AIDS* A comparison of HIV-infected and HIV-negative individuals. Chest. 1997;111:612–8.CrossRefPubMed
9.
go back to reference Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–60.CrossRefPubMed Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–60.CrossRefPubMed
10.
go back to reference Sambatakou H, Dupont B, Lode H, Denning DW. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis. Am J Med. 2006;119(527):e17–24.PubMed Sambatakou H, Dupont B, Lode H, Denning DW. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis. Am J Med. 2006;119(527):e17–24.PubMed
11.
12.
go back to reference Belcher JR, Plummer NS. Surgery in broncho-pulmonary aspergillosis. Br J Dis Chest. 1960;54:335–41.CrossRef Belcher JR, Plummer NS. Surgery in broncho-pulmonary aspergillosis. Br J Dis Chest. 1960;54:335–41.CrossRef
13.
go back to reference Babatasi G, Massetti M, Chapelier A, Fadel E, Macchiatini P, Khayat A, et al. Surgical treatment of pulmonary aspergilloma: current outcome. J Thorac Cardiovasc Surg. 2000;119:906–12.CrossRefPubMed Babatasi G, Massetti M, Chapelier A, Fadel E, Macchiatini P, Khayat A, et al. Surgical treatment of pulmonary aspergilloma: current outcome. J Thorac Cardiovasc Surg. 2000;119:906–12.CrossRefPubMed
14.
15.
go back to reference Faulkner SL, Vernon R, Brown PP, Fisher D, Bender HW. Hemoptysis and pulmonary aspergilloma: Operative versus nonoperative treatment. Ann Thorac Surg. 1978;25:389–92.CrossRefPubMed Faulkner SL, Vernon R, Brown PP, Fisher D, Bender HW. Hemoptysis and pulmonary aspergilloma: Operative versus nonoperative treatment. Ann Thorac Surg. 1978;25:389–92.CrossRefPubMed
16.
go back to reference Serasli E, Kalpakidis V, Iatrou K, Tsara V, Siopi D, Christaki P. Percutaneous bronchial artery embolization in the management of massive hemoptysis in chronic lung diseases. Immediate and long-term outcomes. Int Angiol. 2008;27:319–28.PubMed Serasli E, Kalpakidis V, Iatrou K, Tsara V, Siopi D, Christaki P. Percutaneous bronchial artery embolization in the management of massive hemoptysis in chronic lung diseases. Immediate and long-term outcomes. Int Angiol. 2008;27:319–28.PubMed
17.
go back to reference Giron J, Poey C, Fajadet P, Sans N, Fourcade D, Senac JP, et al. CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 40 cases. Eur J Radiol. 1998;28:235–42.CrossRefPubMed Giron J, Poey C, Fajadet P, Sans N, Fourcade D, Senac JP, et al. CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 40 cases. Eur J Radiol. 1998;28:235–42.CrossRefPubMed
18.
go back to reference Kravitz JN, Berry MW, Schabel SI, Judson MA. A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma. Chest. 2013;143(5):1414–21.CrossRefPubMed Kravitz JN, Berry MW, Schabel SI, Judson MA. A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma. Chest. 2013;143(5):1414–21.CrossRefPubMed
19.
go back to reference Mal H, Rullon I, Mellot F, Brugière O, Sleiman C, Menu Y, et al. Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest. 1999;115:996–1001.CrossRefPubMed Mal H, Rullon I, Mellot F, Brugière O, Sleiman C, Menu Y, et al. Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest. 1999;115:996–1001.CrossRefPubMed
20.
go back to reference Coleman RM, Kaufman L. Use of the immunodiffusion test in the serodiagnosis of aspergillosis. Appl Microbiol. 1972;23:301–8.PubMedPubMedCentral Coleman RM, Kaufman L. Use of the immunodiffusion test in the serodiagnosis of aspergillosis. Appl Microbiol. 1972;23:301–8.PubMedPubMedCentral
21.
go back to reference Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–56.CrossRefPubMed Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–56.CrossRefPubMed
22.
go back to reference World Health Organization. Global Tuberculosis Report; 2013. World Health Organization. Global Tuberculosis Report; 2013.
24.
go back to reference Vazquez EF, Sanz CZ, Dobano JMA, Penela PP, Patiño EG. Hemoptisis de aspergiloma tratada con radioterapia. An Med Intern. 1994;11:516–7. Vazquez EF, Sanz CZ, Dobano JMA, Penela PP, Patiño EG. Hemoptisis de aspergiloma tratada con radioterapia. An Med Intern. 1994;11:516–7.
25.
go back to reference Falkson C, Sur R, Pacella J. External beam radiotherapy: A treatment option for massive haemoptysis caused by mycetoma. Clin Oncol. 2002;14:233–5.CrossRef Falkson C, Sur R, Pacella J. External beam radiotherapy: A treatment option for massive haemoptysis caused by mycetoma. Clin Oncol. 2002;14:233–5.CrossRef
26.
go back to reference Glover S, Holt SG, Newman GH, Kingdon EJ. Radiotherapy for a pulmonary aspergilloma complicating p-ANCA positive small vessel vasculitis. J Infect. 2007;54:e215–7.CrossRefPubMed Glover S, Holt SG, Newman GH, Kingdon EJ. Radiotherapy for a pulmonary aspergilloma complicating p-ANCA positive small vessel vasculitis. J Infect. 2007;54:e215–7.CrossRefPubMed
27.
go back to reference Samuelian JM, Attia A, Jensen C, Monjazeb AM, Blackstock AW. Treatment of hemoptysis associated with aspergilloma using external beam radiotherapy: A case report and literature review. Pract Radiat Oncol. 2011;1:279–81.CrossRefPubMed Samuelian JM, Attia A, Jensen C, Monjazeb AM, Blackstock AW. Treatment of hemoptysis associated with aspergilloma using external beam radiotherapy: A case report and literature review. Pract Radiat Oncol. 2011;1:279–81.CrossRefPubMed
28.
go back to reference Engert A, Plütschow A, Eich HT, Lohri A, Dörken B, Borchmann P, et al. Reduced treatment intensity in patients with early-stage Hodgkin’s lymphoma. N Engl J Med. 2010;363:640–52.CrossRefPubMed Engert A, Plütschow A, Eich HT, Lohri A, Dörken B, Borchmann P, et al. Reduced treatment intensity in patients with early-stage Hodgkin’s lymphoma. N Engl J Med. 2010;363:640–52.CrossRefPubMed
29.
go back to reference Tsuji K, Rahn PD, Steindler KA. 60-Co irradiation as an alternate method for sterilization of penicillin G, neomycin, novobiocin and dehydrostreptomycin. J Pharm Sci. 1983;72:23–6.CrossRefPubMed Tsuji K, Rahn PD, Steindler KA. 60-Co irradiation as an alternate method for sterilization of penicillin G, neomycin, novobiocin and dehydrostreptomycin. J Pharm Sci. 1983;72:23–6.CrossRefPubMed
30.
go back to reference Joujon J, Ballester M, Delcambre F, Mac Bride T, Valat P, Gomez F, et al. Massive hemoptysis: what place for medical and surgical treatment. Eur J Cardiothorac Surg. 2002;22(3):345–51.CrossRef Joujon J, Ballester M, Delcambre F, Mac Bride T, Valat P, Gomez F, et al. Massive hemoptysis: what place for medical and surgical treatment. Eur J Cardiothorac Surg. 2002;22(3):345–51.CrossRef
Metadata
Title
Hemoptysis due to fungus ball after tuberculosis: A series of 21 cases treated with hemostatic radiotherapy
Authors
Lucas G Sapienza
Maria José L Gomes
Carmelindo Maliska
Antonio N Norberg
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-1288-y

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.